Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect

Author:

Boswell F J1,Andrews J M1,Wise R1

Affiliation:

1. Department of Medical Microbiology, City Hospital NHS Trust, Birmingham, United Kingdom.

Abstract

Time-kill kinetics of BAY 12-8039 were studied at two inocula against three strains each of Bacteroides fragilis, Escherichia coli, Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pyogenes. The postantibiotic effects of BAY 12-8039 were studied on three strains each of E. coli, S. aureus, H. influenzae, Streptococcus pyogenes, and Streptococcus pneumoniae. The pharmacodynamic data demonstrated that BAY 12-8039 has marked activity against gram-positive and gram-negative organisms (under both anaerobic and aerobic conditions) and anaerobes. BAY 12-8039 also exhibited a postantibiotic effect of >1 h for all strains except one E. coli strain.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference13 articles.

1. Bactericidal activity of trovafloxacin under anaerobic and aerobic conditions;Boswell F. J.;Infect. Dis. Clin. Pract.,1996

2. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions;Cooper M. A.;J. Antimicrob. Chemother.,1991

3. Craig W. A. and S. Gudmundsson. 1991. Postantibiotic effect p. 403-431. In V. Lorian (ed.) Antibiotics in laboratory medicine 3rd ed. Williams & Wilkins Baltimore Md.

4. Dalhoff A. U. Peterson and R. Endermann. In vitro activity of BAY 12-8039 a new 8-methoxyquinolone. Chemotherapy in press.

5. The killing action of fleroxacin upon Bacteroides fragilis;Griggs D. J.;J. Antimicrob. Chemother.,1989

Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Reply:;Journal of Cataract and Refractive Surgery;2020-01

2. Antibacterial Activity of Synthetic Fire Ant Venom: The Solenopsins and Isosolenopsins;The American Journal of the Medical Sciences;2009-10

3. Moxifloxacin in the treatment of skin and skin structure infections;Therapeutics and Clinical Risk Management;2006-12

4. A Review of New Fluoroquinolones;Treatments in Respiratory Medicine;2006

5. Pharmacodynamics of Moxifloxacin and Levofloxacin Simulating Human Serum and Lung Concentrations*;Infection;2005-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3